CVE-2026-70687: Vulnerability in the Oracle Marketing product of Oracle E-Business Suite (component: Audience)
CVE-2026-70687 is a high-severity flaw (CVSS 7.7) affecting marketing. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Vulnerability in the Oracle Marketing product of Oracle E-Business Suite (component: Audience). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Marketing. While the vulnerability is in Oracle Marketing, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result
Why this priority
- High severity
A fixed release or distro patch exists.
Risk facts
| CVSS score | 7.7 (High) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | 0.4% (top 72%) |
| CISA exploited list | No |
| Weakness | CWE-284 |
| Published | 2026-08-18 |
| Last modified | 2026-10-22 |
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Exact fixes by distribution
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-70687?
marketing: upgrade to newer than 12.2.15. Exact commands for each OS are on this page.
Is CVE-2026-70687 being exploited?
CVE-2026-70687 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-70687 affect?
CVE-2026-70687 affects marketing. Severity is high (CVSS 7.7). Vulnerability in the Oracle Marketing product of Oracle E-Business Suite (component: Audience). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access vi
How urgent is CVE-2026-70687?
Priority 34/100. High severity